Venture capital deals

November 15, 2013, 9:33 PM UTC

GenapSys, a Redwood City, Calif.-based developer of genomic testing systems, has raised $37 million in Series B funding. Yuri Milner and  Stanford StartX Fund were joined by return backers Decheng Capital and IPV Capital.

Catabasis Pharmaceuticals Inc., a Cambridge, Mass.-based developer of medicines to treat inflammatory and metabolic diseases, has raised $32.4 million in Series B funding. Lightstone Ventures led the round, and was joined by an unidentified “public crossover fund” and return backers SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology

BrightTag, a Chicago-based marketing technology platform, has raised $27 million in new VC funding led by Yahoo Japan. The company previously raised around $23 million from TomorrowVentures, Pritzker Group Venture Capital, EPIC Ventures, I2A Fund and Baird Venture

Knozen, a stealthy “personality-probing” startup from TheLadders founder Marc Cenedella, has raised $2.25 million in seed funding, according to TechCrunch. Backers include FirstMark Capital, Lerer Ventures, Greycroft Partners and David Tisch.

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: